Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Probable aminopeptidase PepB | 0.0114 | 0.6584 | 0.5 |
Leishmania major | cytosolic leucyl aminopeptidase,metallo-peptidase, Clan MF, Family M17 | 0.0114 | 0.6584 | 1 |
Echinococcus granulosus | muscleblind protein | 0.0161 | 1 | 1 |
Schistosoma mansoni | PwLAP aminopeptidase (M17 family) | 0.0023 | 0 | 0.5 |
Trypanosoma cruzi | metallo-peptidase, Clan MF, Family M17, putative | 0.0114 | 0.6584 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0161 | 1 | 1 |
Trypanosoma cruzi | cytosolic leucyl aminopeptidase, putative | 0.0114 | 0.6584 | 1 |
Wolbachia endosymbiont of Brugia malayi | leucyl aminopeptidase | 0.0114 | 0.6584 | 0.5 |
Echinococcus multilocularis | leucine aminopeptidase protein | 0.0114 | 0.6584 | 0.6584 |
Trypanosoma brucei | metallo-peptidase, Clan MF, Family M17 | 0.0114 | 0.6584 | 1 |
Echinococcus multilocularis | muscleblind protein 1 | 0.0161 | 1 | 1 |
Mycobacterium leprae | Probable cytosol aminopeptidase PepB | 0.0114 | 0.6584 | 0.5 |
Echinococcus granulosus | leucine aminopeptidase protein | 0.0114 | 0.6584 | 0.6584 |
Toxoplasma gondii | leucyl aminopeptidase LAP | 0.0114 | 0.6584 | 0.5 |
Mycobacterium ulcerans | leucyl aminopeptidase | 0.0114 | 0.6584 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0161 | 1 | 1 |
Plasmodium vivax | M17 leucyl aminopeptidase, putative | 0.0114 | 0.6584 | 0.5 |
Echinococcus multilocularis | muscleblind protein | 0.0161 | 1 | 1 |
Schistosoma mansoni | leucine aminopeptidase | 0.0023 | 0 | 0.5 |
Chlamydia trachomatis | cytosol aminopeptidase | 0.0114 | 0.6584 | 0.5 |
Plasmodium falciparum | M17 leucyl aminopeptidase | 0.0114 | 0.6584 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC (functional) | = 0.03 ug ml-1 | In vitro antibacterial activity against Klebsiella X26 | ChEMBL. | 8230112 |
MIC (functional) | = 0.06 ug ml-1 | In vitro antibacterial activity against Streptococcus pneumoniae PARK | ChEMBL. | 8230112 |
MIC (functional) | = 0.125 ug ml-1 | In vitro antibacterial activity against Haemophilus influenza C.L | ChEMBL. | 8230112 |
MIC (functional) | = 0.25 ug ml-1 | In vitro antibacterial activity against E. coli EC14 | ChEMBL. | 8230112 |
MIC (functional) | = 0.25 ug ml-1 | In vitro antibacterial activity against E. coli EC14 | ChEMBL. | 8230112 |
MIC (functional) | = 0.5 ug ml-1 | In vitro antibacterial activity against Enterobacter aerogenes C32 | ChEMBL. | 8230112 |
MIC (functional) | = 8 ug ml-1 | In vitro antibacterial activity against Staphylococcus aureus X1.1 | ChEMBL. | 8230112 |
MIC (functional) | = 8 ug ml-1 | In vitro antibacterial activity against Staphylococcus epidermidis 222 | ChEMBL. | 8230112 |
MIC (functional) | > 128 ug ml-1 | In vitro antibacterial activity against Pseudomonas PS72 | ChEMBL. | 8230112 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.